MichaelJohnAllinghamMDPhD
Ophthalmology • Durham, NCRetinal Disease
Assistant Professor of Ophthalmology Duke Center for Macular Diseases Duke Eye Center
Dr. Allingham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Education & Training
Duke University HospitalResidency, Ophthalmology, 2010 - 2013- Duke University HospitalInternship, Internal Medicine, 2009 - 2010
University of North Carolina at Chapel Hill School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2013 - 2025
VA State Medical License 2013 - 2020- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Imaging Parameters and DME Treatment Response Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- 162 citationsIncomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities.Priyatham S Mettu, Michael J. Allingham, Scott W. Cousins
Progress in Retinal and Eye Research. 2021-05-01 - 144 citationsKernel regression based segmentation of optical coherence tomography images with diabetic macular edemaStephanie J. Chiu, Michael J. Allingham, Priyatham S Mettu, Scott W. Cousins, Joseph A. Izatt
Biomedical Optics Express. 2015-04-01 - 80 citationsEndothelial cell junctions and the regulation of vascular permeability and leukocyte transmigrationAmir Aghajanian, Erika S. Wittchen, Michael J. Allingham, Tiana A. Garrett, Keith Burridge
Journal of Thrombosis and Haemostasis. 2008-09-01
Press Mentions
Ocuphire Pharma : Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update - Form 8-KAugust 15th, 2022- Ocuphire Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2021 and Provides Corporate UpdateMarch 24th, 2022
Duke Advanced Vitreous Surgery Course – 2018 HighlightsApril 15th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
